Asset profile

ovarian cancer CAR-T therapy · Anixa Biosciences (ANIX)

Indication
ovarian cancer
CompanyANIXAnixa Biosciences

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines se…

On the calendar

Timeline

Newest first.

Oct 13, 2026
08:40 PM
ANIXAnixa Biosciences

Anixa: Dr. Conejo-Garcia to keynote on ovarian cancer CAR-T at Midwest Focus Conference

Conference presentationCompany press release

More from Anixa Biosciences

Other drugs and candidates from the same company tracked in this sector.

ovarian cancer CAR-T therapy · Anixa Biosciences (ANIX) — FDA Timeline & Readiness Checklist | SimianX AI